These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2011 related items for PubMed ID: 12203786

  • 21. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
    Rücker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Fröhling S, Bentz M, Miller S, Scholl C, Schlenk RF, Radlwimmer B, Kestler HA, Pollack JR, Lichter P, Döhner K, Döhner H.
    J Clin Oncol; 2006 Aug 20; 24(24):3887-94. PubMed ID: 16864856
    [Abstract] [Full Text] [Related]

  • 22. Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.
    Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, De Braekeleer M.
    Eur J Haematol; 2007 Jun 20; 78(6):457-67. PubMed ID: 17391336
    [Abstract] [Full Text] [Related]

  • 23. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M, Hélias C, Struski S, Perrusson N, Uettwiller F, Mozziconacci MJ, Lafage-Pochitaloff M, Dastugue N, Terré C, Brizard F, Cornillet-Lefebvre P, Mugneret F, Barin C, Herry A, Luquet I, Desangles F, Michaux L, Verellen-Dumoulin C, Perrot C, Van den Akker J, Lespinasse J, Eclache V, Berger R, Groupe Francophone de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 2007 Jul 01; 176(1):1-21. PubMed ID: 17574959
    [Abstract] [Full Text] [Related]

  • 24. Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes.
    Lindvall C, Furge K, Björkholm M, Guo X, Haab B, Blennow E, Nordenskjöld M, Teh BT.
    Haematologica; 2004 Sep 01; 89(9):1072-81. PubMed ID: 15377468
    [Abstract] [Full Text] [Related]

  • 25. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
    Gao Q, Horwitz M, Roulston D, Hagos F, Zhao N, Freireich EJ, Golomb HM, Olopade OI.
    Genes Chromosomes Cancer; 2000 Jun 01; 28(2):164-72. PubMed ID: 10825001
    [Abstract] [Full Text] [Related]

  • 26. Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype.
    Gross M, Mkrtchyan H, Glaser M, Fricke HJ, Höffken K, Heller A, Weise A, Liehr T.
    Int J Oncol; 2009 Feb 01; 34(2):417-23. PubMed ID: 19148476
    [Abstract] [Full Text] [Related]

  • 27. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ, Li JY, Xiao B, Zhu Y, Liu Q, Pan JL, Qiu HR, Fan L, Zhang SJ, Lu RN, Xu W, Xue YQ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec 01; 24(6):635-9. PubMed ID: 18067073
    [Abstract] [Full Text] [Related]

  • 28. Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.
    Andersen MK, Christiansen DH, Pedersen-Bjergaard J.
    Genes Chromosomes Cancer; 2005 Apr 01; 42(4):358-71. PubMed ID: 15645489
    [Abstract] [Full Text] [Related]

  • 29. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA, Le Beau MM.
    Chem Biol Interact; 2005 May 30; 153-154():187-95. PubMed ID: 15935816
    [Abstract] [Full Text] [Related]

  • 30. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
    Jarosová M, Indrák K, Holzerová M, Hubácek J, Faber E, Papajík T, Raida L, Szotkowski T, Knotková R, Hlusí T, Jedlicková K, Pikalová Z, Sulovská I.
    Vnitr Lek; 2001 Sep 30; 47 Suppl 1():8-14. PubMed ID: 11693065
    [Abstract] [Full Text] [Related]

  • 31. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M, Arenillas L, Espinet B, Salido M, Hernández JM, Lumbreras E, del Rey M, Arranz E, Ramiro S, Font P, González O, Renedo M, Cervera J, Such E, Sanz GF, Luño E, Sanzo C, González M, Calasanz MJ, Mayans J, García-Ballesteros C, Amigo V, Collado R, Oliver I, Carbonell F, Bureo E, Insunza A, Yañez L, Muruzabal MJ, Gómez-Beltrán E, Andreu R, León P, Gómez V, Sanz A, Casasola N, Moreno E, Alegre A, Martín ML, Pedro C, Serrano S, Florensa L, Solé F.
    Haematologica; 2008 Jul 30; 93(7):1001-8. PubMed ID: 18591625
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The value of multiplex fluorescence in situ hybridization in the detection of complex karyotypic abnormalities of acute myeloid leukemia].
    Ma L, Li JY, Pan JL, Xiao B, Qian SX, Chen LJ, Qiu HR, Wen BZ, Xue YQ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 30; 27(5):318-22. PubMed ID: 16875581
    [Abstract] [Full Text] [Related]

  • 35. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
    González MB, Gutiérrez NC, García JL, Schoenmakers EF, Solé F, Calasanz MJ, San Miguel JF, Hernández JM.
    Cancer Genet Cytogenet; 2004 Apr 15; 150(2):136-43. PubMed ID: 15066321
    [Abstract] [Full Text] [Related]

  • 36. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.
    Barbouti A, Johansson B, Höglund M, Mauritzson N, Strömbeck B, Nilsson PG, Tanke HJ, Hagemeijer A, Mitelman F, Fioretos T.
    Genes Chromosomes Cancer; 2002 Oct 15; 35(2):127-37. PubMed ID: 12203776
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM.
    Cancer Surv; 1992 Oct 15; 15():143-59. PubMed ID: 1451109
    [Abstract] [Full Text] [Related]

  • 39. Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype.
    Prowald A, Wemmert S, Biehl C, Storck S, Martin T, Henn W, Ketter R, Meese E, Zang KD, Steudel WI, Urbschat S.
    Int J Oncol; 2005 Feb 15; 26(2):385-93. PubMed ID: 15645123
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 101.